Treatment of infections caused by carbapenemase-producing Enterobacterales.
Rev Esp Quimioter
; 35 Suppl 3: 46-50, 2022 Oct.
Article
in En
| MEDLINE
| ID: mdl-36285858
ABSTRACT
Antibiotic resistance is one of the main menaces to public and individual health worldwide. In the last two decades, an increase in the detection of carbapenem-resistant Enterobacterales has been reported. The treatment of infections caused by these strains is a therapeutic challenge. The use of carbapenems may be beneficial depending on MIC value and source of infection. New drugs, with different activity against the different classes of carbapenemases, are developed showing significant benefits.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bacterial Proteins
/
Beta-Lactamases
Limits:
Humans
Language:
En
Journal:
Rev Esp Quimioter
Journal subject:
TERAPIA POR MEDICAMENTOS
Year:
2022
Document type:
Article